Kocarek T A, Feller D R
Division of Pharmacology, College of Pharmacy, Ohio State University, Columbus 43210.
Biochem Pharmacol. 1989 Dec 1;38(23):4169-76. doi: 10.1016/0006-2952(89)90511-x.
Potencies for the induction of peroxisomal fatty acyl-CoA oxidase (FACO) and microsomal laurate hydroxylase (LH) were determined for clofibric acid (CPIB), ciprofibrate (Cipro) and gemfibrozil (Gem) in primary cultures of rat hepatocytes based on complete concentration-response analysis and determination of theoretical maximum inductive responses for Cipro. CPIB and Cipro each induced FACO and LH in a concentration-dependent manner. Scatchard analysis of the data allowed calculation of EC50 values (mM) of 0.82 and 0.028 (for FACO) and 0.22 and 0.0081 (for LH) for CPIB and Cipro respectively. The EC50 ratios (CPIB/Cipro) were identical (29-fold) for induction of FACO and LH, supporting the concept that these enzymes are induced by CPIB and Cipro through a common mechanism. By comparison, Gem was relatively ineffective as an inducer of FACO and LH. Furthermore, Gem did not antagonize Cipro-mediated enzyme inductions, suggesting that Gem is a peroxisome proliferator of low potency rather than a partial agonist. Based on the potency and time-course profiles observed for induction of FACO and LH, the effects of CPIB, Cipro and Gem on triglyceride (TG) biosynthesis were determined in the cultured rat hepatocytes. Conditions of maximal FACO and LH induction by the drugs did not result in inhibition of TG biosynthesis in the cells. These results support the in vivo evidence which indicates that FACO and LH induction are not causally linked to the hypotriglyceridemic actions of peroxisome proliferating drugs.
基于完整的浓度 - 反应分析以及对环丙贝特(Cipro)理论最大诱导反应的测定,在大鼠原代肝细胞培养物中测定了氯贝酸(CPIB)、环丙贝特和吉非贝齐(Gem)诱导过氧化物酶体脂肪酸酰基辅酶A氧化酶(FACO)和微粒体月桂酸羟化酶(LH)的效力。CPIB和环丙贝特均以浓度依赖性方式诱导FACO和LH。对数据进行Scatchard分析后,分别计算出CPIB和环丙贝特诱导FACO的EC50值(mM)为0.82和0.028,诱导LH的EC50值为0.22和0.0081。诱导FACO和LH时,EC50比值(CPIB/环丙贝特)相同(29倍),这支持了这些酶由CPIB和环丙贝特通过共同机制诱导的观点。相比之下,吉非贝齐作为FACO和LH的诱导剂相对无效。此外,吉非贝齐不拮抗环丙贝特介导的酶诱导作用,表明吉非贝齐是一种低效的过氧化物酶体增殖剂,而非部分激动剂。基于诱导FACO和LH时观察到的效力和时间进程曲线,在培养的大鼠肝细胞中测定了CPIB、环丙贝特和吉非贝齐对甘油三酯(TG)生物合成的影响。药物诱导FACO和LH达到最大值的条件并未导致细胞中TG生物合成受到抑制。这些结果支持了体内证据,即FACO和LH的诱导与过氧化物酶体增殖药物的降甘油三酯作用没有因果关系。